Latest for ATTR Amyloidosis (Transthyretin Amyloidosis)
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about ATTR Amyloidosis (Transthyretin Amyloidosis)
For the heart form, most people are diagnosed without a biopsy: once blood and urine tests rule out AL amyloidosis, a PYP, DPD or HMDP bone scan showing grade 2 or 3 heart uptake confirms ATTR, and TTR gene sequencing separates hereditary from wild-type. The nerve form usually needs nerve testing, a tissue biopsy and genetic testing. A TTR variant alone does not confirm the disease; carriers are monitored, usually starting 10 years before the age their relatives got sick. Early detection through screening of at-risk populations is crucial since treatments work best when started early.
Keep reading about ATTR Amyloidosis (Transthyretin Amyloidosis)
Multiple FDA-approved therapies now address ATTR amyloidosis. TTR stabilizers like tafamidis and acoramidis prevent protein misfolding and aggregation. Gene-silencing therapies including vutrisiran and eplontersen reduce TTR production. Ongoing research focuses on TTR depleters that remove existing amyloid deposits.
What are the symptoms of ATTR Amyloidosis (Transthyretin Amyloidosis)?
These are common symptoms of ATTR Amyloidosis (Transthyretin Amyloidosis), and how strong they are varies from person to person.
- Shortness of breath and progressive heart failure
- Irregular heartbeat and atrial fibrillation
- Leg swelling (edema) and fluid retention
- Peripheral neuropathy with tingling, numbness, or weakness in feet and legs
- Lightheadedness or fainting from cardiac conduction problems
- Autonomic dysfunction including low blood pressure on standing and GI issues
Who gets ATTR Amyloidosis (Transthyretin Amyloidosis)?
Hereditary ATTR typically emerges in middle age, though onset varies significantly by geographic region and specific mutation. About 3-4% of African Americans carry the Val122Ile (V122I) variant. Wild-type ATTR predominantly affects males over 60.
Next steps: find trials you might fitcompare treatmentsget help payingget alerts
Which medicines are FDA-approved for ATTR Amyloidosis (Transthyretin Amyloidosis)?
There are currently 5 FDA-approved medications for ATTR Amyloidosis (Transthyretin Amyloidosis).
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
Which new ATTR Amyloidosis (Transthyretin Amyloidosis) medicines are in trials?
Investigational medicines Trial Friend tracks for ATTR Amyloidosis (Transthyretin Amyloidosis), with trial results, safety findings and where each one stands.
How to get help paying for ATTR Amyloidosis (Transthyretin Amyloidosis) treatment
Charity funds and drugmaker programs for ATTR Amyloidosis (Transthyretin Amyloidosis), checked at the source.
- From a charity · NORD RareCareAmyloidosis Medical Assistance fundWaitlist
Pays for: Medical and medication costs.
The foundation says: “Temporarily Waitlisting” - From a charity · NORD RareCareAmyloidosis Premium Copay Assistance fundWaitlist
Pays for: Insurance premiums and copays.
The foundation says: “Temporarily Waitlisting” - From a charity · The Assistance FundAmyloidosis fundWaitlist
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
- Onpattro (Patisiran) · Alnylam Assist
- Amvuttra (Vutrisiran) · Alnylam Assist
- Vyndamax (Tafamidis) · VynAssist / VyndaLink
- Attruby (Acoramidis) · ForgingBridges
- Wainua (Eplontersen) · WAINUA WAY (AstraZeneca Access 360)
Every program and fund for ATTR Amyloidosis (Transthyretin Amyloidosis), by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for ATTR Amyloidosis (Transthyretin Amyloidosis)
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
The TTR gene page lists every condition Orphanet links to the gene and the open trials that name it.
Finding labs...
Trusted ATTR Amyloidosis (Transthyretin Amyloidosis) resources
Reputable organizations and medical references for learning more about ATTR Amyloidosis (Transthyretin Amyloidosis), including disease registries, foundation resources, and clinical guidelines.